Professor of Cardiovascular Physiology and Metabolism and a Wellcome Trust Research Fellow at the William Harvey Research Institute (WHRI), Barts and London Faculty of Medicine and Dentistry. Joined Queen Mary in November 2017 in the first faculty post after 9 years cardiovascular research postdoctoral training at the British Heart Foundation (BHF) Research Excellence Centres: Oxford and King’s College London (KCL). At Oxford in Prof Stefan Neubauer’s group, Prof Aksentijevic was responsible for all the physiological metabolism aspects of the British Heart Foundation research programmes investigating the pharmacology of augmenting cellular ATP reserve in heart failure. At KCL in Prof Michael Shattock’s group, she used her extensive physiological metabolism experience to interface in situ NMR spectroscopy with physiological techniques to study modulation of myocardial sodium regulation. This work resulted in a major scientific advancement published in Nature Communications garnering international press coverage (BBC World Service) as well as press releases by KCL and WHRI. Over the past decade, Prof Aksentijevic collaborated with Professor Mike Murphy’s group at Cambridge on a breakthrough study to show that succinate accumulation is a universal metabolic signature of ischaemia/reperfusion injury. Prof Aksentijevic is ranked in the top 0.58% published cardiac energy metabolism experts worldwide (Expertscape, >40 publications, citations >4500). Her research group at WHRI explores metabolic mechanisms of heart failure and her work is funded by the British Heart Foundation, Wellcome Trust, Diabetes UK, Barts Charity and Astra Zeneca.